| The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing TJ Pugh, MA Kelly, S Gowrisankar, E Hynes, MA Seidman, SM Baxter, ... Genetics in Medicine 16 (8), 601-608, 2014 | 358 | 2014 |
| Sponsorship of national health organizations by two major soda companies DG Aaron, MB Siegel American journal of preventive medicine 52 (1), 20-30, 2017 | 94 | 2017 |
| Is obesity a manifestation of systemic racism? A ten‐point strategy for study and intervention DG Aaron, FC Stanford Journal of internal medicine 290 (2), 416-420, 2021 | 46 | 2021 |
| Constitutional cohesion and the right to public health JG Hodge Jr, D Aaron, HR Augur, A Cheff, J Daval, D Hensley U. Mich. JL Reform 53, 173, 2019 | 17 | 2019 |
| Tobacco reborn: the rise of e-cigarettes and regulatory approaches DG Aaron Lewis & Clark L. Rev. 25, 827, 2021 | 15 | 2021 |
| Medicine, structural racism, and systems DG Aaron, FC Stanford Social Science & Medicine 298, 114856, 2022 | 14 | 2022 |
| Ten years post-GAO assessment, FDA remains uninformed of potentially harmful GRAS substances in foods C Faustman, D Aaron, N Negowetti, EB Leib Critical Reviews in Food Science and Nutrition 61 (8), 1260-1268, 2021 | 11 | 2021 |
| The fall of FDA review D Aaron Yale Journal of Health Policy, Law, and Ethics 22, 95-191, 2023 | 10 | 2023 |
| The FDA struggle to withdraw Makena: problems with the accelerated approval process DG Aaron, IG Cohen, EY Adashi JAMA 328 (24), 2394-2395, 2022 | 8 | 2022 |
| Public Health in the Opioid Litigation DG Aaron Loy. U. Chi. LJ 53, 11-87, 2021 | 6 | 2021 |
| Court Intrusion Into Science and Medicine—The Mifepristone Decisions DG Aaron, TR Brown, MS Sinha JAMA 329 (20), 1735-1737, 2023 | 5 | 2023 |
| Supreme Court cases on affirmative action threaten diversity in medicine DG Aaron, SS Bajaj, FC Stanford Proceedings of the National Academy of Sciences 120 (17), e2220919120, 2023 | 5 | 2023 |
| Opioid Accountability DG Aaron Tenn. L. Rev. 89, 611, 2022 | 4 | 2022 |
| Including E-Cigarettes in the FDA Rule Limiting Nicotine DG Aaron, CR Wallace, MS Sinha JAMA, 2023 | 3 | 2023 |
| Lawsuits Over the Price of Insulin—State Efforts for Insulin Access DG Aaron, IG Cohen, EY Adashi JAMA Internal Medicine 184 (1), 9-10, 2024 | 1 | 2024 |
| US Supreme Court Limits on the Power of US Health Agencies DG Aaron, AE Emery JAMA, 2024 | | 2024 |
| Consumer Protection, Agencies, and the Supreme Court DG Aaron, CL Peterson JAMA Health Forum 5 (4), e240254-e240254, 2024 | | 2024 |
| Immunity Through Bankruptcy for the Sackler Family DG Aaron, MS Sinha West Virginia Law Review, Forthcoming, 2024 | | 2024 |
| E-Cigarettes and FDA Nicotine Cap—Reply DG Aaron, MS Sinha JAMA 331 (4), 359-360, 2024 | | 2024 |
| The Supreme Court’s 303 Creative Decision and the Threat to LGBTQ+ Health Care EW Sepper, JB Romero, DG Aaron JAMA, 2023 | | 2023 |
Fatima Cody Stanford, MD, MPH, MPA...Massachusetts General Hospital/ Harvard Medical SchoolVerified email at mgh.harvard.edu
